It promotes malignant transformation by activating the STAT3 signaling pathway, thereby regulating genes involved in cell cycle progression and survival, and its expression is positively correlated with advanced clinicopathological features of breast cancer (Pandey et al., 2018). The gene discussed is STAT3; the disease is breast carcinoma.